Olympus jumps through final anti-trust hoops for Gyrus acquisition
This article was originally published in Clinica
Executive Summary
Olympus' proposed £935m ($1.8bn) acquisition of UK firm Gyrus has received the go-ahead from anti-trust authorities in Germany and Austria. In addition to the US approval gained in December 2007, the transaction has cleared all the required anti-trust hurdles. Gyrus, which specialises in minimally-invasive surgery, agreed to be acquired by Japanese group Olympus in November for £6.30 per share (see Clinica No 1283, p 1).